SynBioBeta Speaker
Daniel de la Torre
Constructive Bio
VP of R&D
Daniel is VP of R&D at Constructive Bio. After completing his BSc in Biotechnology at University College London, he obtained his PhD at Prof. Chin’s lab at the MRC Laboratory of Molecular Biology, where he developed foundational technologies for genome synthesis, being part of a core team that created Syn61, a synthetic strain of E. coli that uses 61 codons, as opposed to 64, to make its proteins. In subsequent postdoctoral work in the Chin lab, Daniel reprogrammed the genetic code of Syn61 to enable the production of proteins containing 3 different non-natural amino acids. Daniel currently leads platform research at Constructive Bio, looking to reprogram the genetic code of living cells for the sustainable, genetically-encoded bioproduction of valuable biomolecules.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Daniel
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
